Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Acadia Pharmaceuticals has reported net loss of $6.56m for the second quarter ended 30 June 2011, compared to $4.29m for the same period in 2010.
Subscribe to our email newsletter
The company’s loss from operations for the second quarter of 2011 was $6.58m, compared to $4.3m for the same period in 2010.
For the six months ended 30 June 2011, the company reported a net loss of $12.39m, compared to $9.78m for the same period in 2010.
Acadia Pharma’s loss from operations was $12.45m for the six months of 2011, compared to $9.79m for the same period in 2010.
Acadia Pharma CEO Uli Hacksell said they continue to enroll patients in the ongoing -020 Phase III efficacy, tolerability and safety study and the -015 Phase III open-label safety extension study.